Pro 2012-008 (Jianfeng Group's Announcement on Mutual Insurance of Kane Shares)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2012-008
Zhejiang Jianfeng Group Co., Ltd.
External Guarantee Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Content Tips
● Name of Guarantor: Zhejiang Kane Special Materials Co., Ltd.
● Quantity of this guarantee: RMB 50 million Yuan
● Is there any counter-guarantee for this guarantee: this guarantee is based on the principle of equal mutual guarantee
● As of the date of this disclosure, the balance of the company's external guarantee is 348.8 million yuan
● Cumulative quantity of overdue external guarantee: no
1. guarantee overview
On April 6, 2012, Zhejiang Jianfeng Group Co., Ltd. held the fourth meeting of the 8th Board of Directors. The meeting should have nine directors, actually nine, in line with the relevant provisions of the Company Law and the articles of Association, and the resolutions made are legal and effective. The meeting was presided over by Chairman Jiang Xiaomeng. After deliberation and voting, the proposal on external guarantee was deliberated and passed with 9 votes in favor, 0 against and 0 abstention.
agreed to implement a mutual guarantee with Zhejiang Kane Special Materials Co., Ltd. with a quota of 50 million yuan for a period of one year. The external guarantee matters shall be submitted to the general meeting of shareholders for consideration and approval before implementation.
Basic Information of 2. Guarantees
Zhejiang Kane Special Materials Co., Ltd. was listed on Shenzhen Stock Exchange on July 5, 2004 with stock code: 002012; Registered capital of the company: 23381.27 yuan, registered address: 1008 Kane Road, Suichang County, Zhejiang Province; Legal representative of the company: Ji Hao; Scope of business: electronic materials, paper and paper products manufacturing, processing, sales; papermaking raw materials , such as .
Key Financial Data of Kane Shares (Unit: ten thousand yuan)
total assets |
net assets |
main business income |
net profit |
|
December 2011 31st |
165753.04 |
106799.16 |
96175.09 |
11813.83 |
the main contents of the 3. guarantee agreement
passed this time to Zhejiang the guarantee of Kane Special Materials, Inc, it is a mutual guarantee with which the company will enter into a mutual insurance agreement for a period of one year after the company has fulfilled the relevant procedures. And request the general meeting of shareholders to authorize the guarantee within the amount to be executed by the chairman of the board of directors in accordance with the actual situation.
4. Board Opinion
Zhejiang Kane Special Materials Co., Ltd. is a listed company with transparent financial information, good operating performance and the ability to repay debts. The board of directors agrees to mutually guarantee with it.
5. Cumulative Number of External Guarantees and Number of Overdue Guarantees
As of the date of this disclosure, the balance of the Company's external guarantees is 348.8 million yuan. No overdue guarantee.
Catalogue of 6. Documents for Reference
1 , Resolution of the Fourth Meeting of the Eighth Board of Directors of the Company;
2 , photocopy of the guaranteed person's business license;
hereby announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
April 6, 2012
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page